泰加(06161.HK)撤回本月初發出的士保險退保通知書
保監局早前根據《保險業條例》賦予的權力,委任德勤的黎嘉恩和甘仲恆爲泰加保險共同及各別經理,全面接管泰加保險(06161.HK)的所有事務及資產。經理日前代表泰加,作爲承保方撤銷於今年1月3日及4日所發出的的士保險保單退保通知書。
經理表示,目前仍在瞭解泰加的經營及財務狀況,爲保障客戶利益,未能爲於今年2月到期的的士保險安排續保。
此外,泰加正爲已收到泰加於去年12月30日發出退保通知書的保單持有人,安排退保及有序地退還剩餘保費,如該類保單持有人仍未找到保險公司承接其保險,泰加將爲受影響並且有需要的保單持有人安排將其保單最多延長至2022年2月5日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.